RemovedRisk Factors
amounts owed to them or, where applicable, trigger a cross-default, cancel their commitments to lend or issue letters of credit or, where the reimbursement obligations are unsecured, require us to pledge collateral or, where the reimbursement obligations are secured, require us to pledge additional or a different type of collateral.
Read it in 10-K Feb 12, 2025 at sec.govopen_in_new
RemovedRisk Factors
The principal markets in which we operate are susceptible to monetary inflation, which could cause loss costs to increase, impact the performance of our investment portfolio, and borrowing costs to increase. We
Read it in 10-K Feb 12, 2025 at sec.govopen_in_new
RemovedRisk Factors
cause our results of operations to be more volatile. Our significant third-party capital management operations further complicates these foreign currency operational needs and risk.
Read it in 10-K Feb 12, 2025 at sec.govopen_in_new
RewordedRisk Factors
Our investment assets could may be affected by a market shift shifts away from carbon-intensive industries or businesses, sectors, increased costs or fees associated with the production of greenhouse gases, and decreased reduced profitability in sectors that produce or use rely on carbon-based fuels. fuels, or by societal or market shifts related to these trends.
Read it in 10-K Feb 11, 2026 at sec.govopen_in_new
RewordedRisk Factors
The development and adoption As part of these ComFrame, the IAIS developed global risk-based insurance capital standards that, if applied to us, could increase our prescribed capital requirement, the level at which of regulatory scrutiny intensifies, on the level of capital we maintain, limit intercompany capital transactions, suspend debt repayments, and significantly increase our cost of regulatory compliance.
Read it in 10-K Feb 11, 2026 at sec.govopen_in_new
RewordedRisk Factors
While we are at a relatively attractive point in the cycle, However, rates recently have, and may in the future, decrease in certain lines of business, and we cannot assure you that the higher premium rates will continue. business.
Read it in 10-K Feb 11, 2026 at sec.govopen_in_new
RewordedRisk Factors
We are subject Our failure to cybersecurity risks, which may harm carry out our business or reputation, and which could plans may have an adverse effect on our business strategy, long-term results of operations, or operations and financial condition.
Read it in 10-K Feb 11, 2026 at sec.govopen_in_new
RewordedRisk Factors
In addition, we believe that certain factors may continue to increase the number and severity of claims from catastrophic events in the future, including increases in the value and geographic concentration of insured property, increasing risks associated with extreme weather events because of changes in climate conditions and sea-level rise, and the effects of higher-than-expected inflation.
Read it in 10-K Feb 11, 2026 at sec.govopen_in_new
RewordedRisk Factors
In addition to the potential impacts that environmental incidents events may have on our business, there are also risks to our business arising from the related to a transition to a lower carbon economy, including from proliferation of increased governmental and regulatory scrutiny related to climate change climate-related risk and greenhouse gases. gas emissions.
Read it in 10-K Feb 11, 2026 at sec.govopen_in_new
RewordedRisk Factors
For example, it is possible that substantial losses ceded to the alternative capital sector over a period of years, and restraints on capital return and maintenance of collateral for prior loss periods by a number of market participants, may contribute to a reduction in investor appetite to this product class in the near term.
Read it in 10-K Feb 11, 2026 at sec.govopen_in_new
RewordedRisk Factors
Further While the Federal Reserve reduced the federal funds target rate in 2025, further increases in interest rates could cause the market value of our investment portfolio to decrease, which could reduce our capital resources. resources over the near-to medium-term.
Read it in 10-K Feb 11, 2026 at sec.govopen_in_new
RewordedRisk Factors
The insurance and reinsurance regulatory framework is subject to heavy scrutiny by the U.S. and individual state governments, as well as a number of international authorities, and we believe it is likely there this will be increased regulatory intervention in our industry in continue into the future, including potential additional group-wide supervision. foreseeable future.
Read it in 10-K Feb 11, 2026 at sec.govopen_in_new
RewordedRisk Factors
To the extent the jurisdictions in which we operate incorporate this guidance into their own laws, our overall future cash tax savings from the reversal of the deferred tax asset could be limited to the lesser of 20% of the gross deferred tax asset or the portion of the deferred tax asset that reverses is expected to reverse in 2025 and 2026.
Read it in 10-K Feb 11, 2026 at sec.govopen_in_new
RewordedRisk Factors
Concerns over the negative impacts of climate change Climate-related concerns have led led, and will may continue to lead lead, to new regulatory responses.
Read it in 10-K Feb 11, 2026 at sec.govopen_in_new
RewordedRisk Factors
We expect to incur increased Our tax liabilities and reporting obligations have increased and may continue to increase as a result of the implementation of the CIT in Bermuda and the GloBE Pillar II Rules in other jurisdictions where we operate.
Read it in 10-K Feb 11, 2026 at sec.govopen_in_new
Quiet changesRisk Factors
Effective January 1, 2025, the CIT generally will impose imposes a 15% income tax on our profits generated in Bermuda (except for profits earned by our joint ventures and managed funds), notwithstanding any assurances that may have been provided pursuant to the Exempted Undertakings Tax Protection Act 1966.
Read it in 10-K Feb 11, 2026 at sec.govopen_in_new
Quiet changesRisk Factors
In addition, many Some jurisdictions in which our insurance and reinsurance subsidiaries operate have laws and regulations that require regulatory approval of a change in control of an insurer or an insurer’s holding company.
Read it in 10-K Feb 11, 2026 at sec.govopen_in_new
AddedMD&A
Our expenses primarily consist of: (1) net claims and claim expenses incurred on the policies of reinsurance and insurance we sell; (2) acquisition costs, which typically represent a percentage of the premiums we write; (3) operational expenses, which primarily consist of personnel expenses, rent and other expenses; (4) corporate expenses, which include certain executive, legal and consulting expenses, costs for research and
Read it in 10-K Feb 11, 2026 at sec.govopen_in_new
AddedMD&A
We manage several entities - DaVinci, Fontana, Medici, and Vermeer - where we control the decision making authority through ownership of the voting interests but do not own all of the economic interest. As a result of our control, we include the full financial results of these entities in our consolidated financial statements. However, since we do not own all of the economic interest in these entities, we do not ultimately retain all of the economic outcomes they generate. Rather, portions of these entities’ economic outcomes are due to third-party investors who hold noncontrolling interests in these entities and are ultimately allocated to such third-party investors.
Read it in 10-K Feb 11, 2026 at sec.govopen_in_new
AddedMD&A
anticipated effects of inflation on us in our catastrophe loss models and on our investment portfolio. Our estimates of the potential effects of inflation are also considered in pricing and in estimating reserves for unpaid claims and claim expenses. The potential exists, after a catastrophe loss, for the development of inflationary pressures in a local economy.
Read it in 10-K Feb 11, 2026 at sec.govopen_in_new
AddedMD&A
In March 2025 we launched Medici UCITS, a new Irish domiciled property catastrophe bond fund, a sub-fund of RenaissanceRe Medici ICAV. Medici UCITS is purpose-built to provide European and other global investors with access to RenaissanceRe’s catastrophe bond investment strategy through a dedicated European-regulated UCITS structure. Medici UCITS launched with $341.5 million in total capital, made up of a combination of primarily existing partner capital, new partner capital and a $140.0 million co-investment from the Company. At launch, Medici UCITS was seeded by a transfer in kind of catastrophe bonds of Medici. Medici UCITS is intended to complement our existing catastrophe bond fund, Medici, and both Medici UCITS and Medici share substantially similar investment guidelines and risk appetites. Medici is consolidated within our results, whereas Medici UCITS is not controlled by us, and is therefore not consolidated within our results. RenaissanceRe’s investment in Medici UCITS appears as a fund investment and is accounted for at fair value. The transactions related to the launch of Medici UCITS appear in our financial statements as a reduction in the overall net asset value of Medici of $316.5 million at December 31, 2025, and our investment in Medici UCITS appears as a fund investment of $154.5 million at December 31, 2025. Refer to “Note 5. Investments” in our “Notes to the Consolidated Financial Statements” for additional information related to our investment in Medici UCITS.
Read it in 10-K Feb 11, 2026 at sec.govopen_in_new
AddedMD&A
Our estimates of large losses are based on factors including currently available information derived from claims information from certain customers and brokers, industry assessments of losses, proprietary models, historical reinsurance and insurance loss experience and statistics, management’s experience and judgment to assist the establishment of appropriate claims and claim expense reserves, and the terms and
Read it in 10-K Feb 11, 2026 at sec.govopen_in_new
AddedMD&A
or decrease in reinsurance recoveries, loss related premium or profit commission, income tax benefit (expense), or redeemable noncontrolling interest.
Read it in 10-K Feb 11, 2026 at sec.govopen_in_new
AddedMD&A
Due to the nature of reinsurance, ceding companies routinely report and remit premiums to us subsequent to the contract coverage period. Consequently, premiums written and receivable include amounts reported
Read it in 10-K Feb 11, 2026 at sec.govopen_in_new
AddedMD&A
recoverable balances. To reflect these uncertainties, we estimate and record a provision for current expected credit losses for potential uncollectible reinsurance recoverable which reduces reinsurance recoverable and net income.
Read it in 10-K Feb 11, 2026 at sec.govopen_in_new
AddedMD&A
and correlations of such inputs, some of which may be unobservable, to value these Level 3 assets and liabilities.
Read it in 10-K Feb 11, 2026 at sec.govopen_in_new
AddedMD&A
uncertainty embedded in our financial statements, and potentially increase the volatility of our reported results.
Read it in 10-K Feb 11, 2026 at sec.govopen_in_new
AddedMD&A
(1)In 2025, the Company revised its presentation of “total investment result” to include equity in earnings (losses) of other ventures. Comparative information for the prior periods presented have been updated to conform to the current presentation.
Read it in 10-K Feb 11, 2026 at sec.govopen_in_new
AddedMD&A
–underwriting income of $1.3 billion, a decrease of $352.3 million, and an increase in the combined ratio of 3.3 percentage points, driven primarily by:
Read it in 10-K Feb 11, 2026 at sec.govopen_in_new
RemovedMD&A
On November 1, 2023, we completed the Validus Acquisition, pursuant to which we acquired Validus Holdings and Validus Specialty. We accounted for the Validus Acquisition under the acquisition method of accounting in accordance with FASB ASC Topic 805, Business Combinations.
Read it in 10-K Feb 12, 2025 at sec.govopen_in_new
RemovedMD&A
On November 1, 2023, we completed the Validus Acquisition in accordance with the Stock Purchase Agreement dated May 22, 2023 between RenaissanceRe Holdings Ltd. and American International Group, Inc., a Delaware corporation and NYSE-listed company, pursuant to which, upon the terms and subject to the conditions thereof, we, or one of our subsidiaries, purchased, acquired and accepted from certain subsidiaries of AIG, all of their right, title and interest in the shares of Validus Holdings, Ltd. and Validus Specialty, LLC. Substantially all of the assets of Validus Holdings are comprised of its equity interest in its wholly-owned subsidiary, Validus Reinsurance, Ltd. Pursuant to the Stock Purchase Agreement, we also acquired the renewal rights, records and customer relationships of the assumed treaty reinsurance business of Talbot Underwriting Limited, an affiliate of AIG, a specialty (re)insurance group operating within the Lloyd’s market.
Read it in 10-K Feb 12, 2025 at sec.govopen_in_new
RemovedMD&A
In connection with the Validus Acquisition, on November 1, 2023, we paid to AIG aggregate consideration of $2.985 billion, consisting of the following: (i) cash consideration of $2.735 billion; and (ii) 1,322,541 common shares, which were valued at approximately $250.0 million based on a value of $189.03 per share at signing, pursuant to the Stock Purchase Agreement. The value of the acquisition consideration was $3.020 billion as of the closing date. We also entered into a registration rights agreement with AIG in respect of the shares issued to AIG. AIG also received an option to make a substantial investment into our Capital Partners vehicles, which was exercised effective January 1, 2024.
Read it in 10-K Feb 12, 2025 at sec.govopen_in_new
RemovedMD&A
We believe that the Validus Acquisition has several significant strategic benefits for us. We believe that it advances our strategy as a global property and casualty reinsurer, providing additional scale and increasing our importance with customers and brokers. Through the Validus Acquisition, we gained access to a large, attractive book of reinsurance business that was closely aligned with our existing business mix, accelerating our growth in a favorable market. We believe our increased scale following the Validus Acquisition positions us among the five largest global property and casualty reinsurers. The Validus Acquisition was immediately accretive to our shareholders upon completion. At the same time, we have deepened, and intend to continue to deepen, our relationship with a core trading partner, AIG, who is one of our five largest clients by premium volume, as the Validus Acquisition provides options for increased future strategic engagement.
Read it in 10-K Feb 12, 2025 at sec.govopen_in_new
RemovedMD&A
(1)The previously reported amount has been adjusted to reclassify certain reserves from IBNR to ACR.
Read it in 10-K Feb 12, 2025 at sec.govopen_in_new
RemovedMD&A
(2)Represents the fair value of Validus’ reserve for claims and claim expenses, net of reinsurance recoverable, acquired on November 1, 2023.
Read it in 10-K Feb 12, 2025 at sec.govopen_in_new
RemovedMD&A
table below. For incurred accident year claims denominated in currencies other than USD, we have used the current year-end balance sheet foreign exchange rate for all periods provided, thereby eliminating the effects of changes in foreign currency translation rates from the incurred accident year claims development information included in the table below.
Read it in 10-K Feb 12, 2025 at sec.govopen_in_new
RemovedMD&A
As each accident year has developed, our estimated expected incurred claims and claim expenses, net of reinsurance, have changed. For example, our re-estimated incurred claims and claim expenses decreased for the 2021 accident year from the initial estimates. This decrease was principally driven by actual reported and paid net claims and claim expenses associated with the 2021 accident year being lower than expected, which has resulted in a reduction in our expected ultimate claims and claim expense ratio for this accident year. In comparison, the 2019 accident year has developed adversely compared to our initial estimates of incurred claims and claim expenses and our current estimates are higher than our initial estimates. The increase in incurred claims and claim expenses for the 2019 accident year is due to reported losses generally coming in higher than expected on attritional net claims and claim expenses.
Read it in 10-K Feb 12, 2025 at sec.govopen_in_new
RemovedMD&A
The following filed income tax returns are open for examination with the applicable tax authorities: tax years 2018 through 2023 with the U.S.; 2020 through 2023 with Ireland; 2022 through 2023 with the U.K.; 2020 through 2023 with Singapore; 2021 through 2023 with Switzerland; 2020 through 2023 with Australia; 2020 through 2023 with Canada; and 2019 through 2023 with Luxembourg. We do not expect the resolution of these open years to have a significant impact on our consolidated statements of operations and financial condition.
Read it in 10-K Feb 12, 2025 at sec.govopen_in_new
RemovedMD&A
•Underwriting Results - we generated underwriting income of $1.6 billion and had a combined ratio of 83.9% in the year ended December 31, 2024, compared to underwriting income of $1.6 billion and a combined ratio of 77.9% in the year ended December 31, 2023. Our underwriting income in the year ended December 31, 2024 was comprised of our Property segment, which generated underwriting income of $1.6 billion and had a combined ratio of 57.2%, and our Casualty and Specialty segment, which incurred an underwriting loss of $25.4 million and had a combined ratio of 100.4%. In comparison, our underwriting income in the year ended December 31, 2023 was comprised of our Property segment, which generated underwriting income of $1.4 billion and had a combined ratio of 53.4%, and our Casualty and Specialty segment, which generated underwriting income of $208.1 million and had a combined ratio of 95.2%;
Read it in 10-K Feb 12, 2025 at sec.govopen_in_new
RemovedMD&A
•Gross Premiums Written - our gross premiums written increased by $2.9 billion, or 32.4%, to $11.7 billion, in the year ended December 31, 2024, compared to the year ended December 31, 2023. This was comprised of an increase of $1.6 billion in our Casualty and Specialty segment and an increase of $1.3 billion in our Property segment, both primarily driven by the renewal of business acquired in the Validus Acquisition, in conjunction with organic growth on legacy lines;
Read it in 10-K Feb 12, 2025 at sec.govopen_in_new
RemovedMD&A
•Investment Results - our total investment result, which includes the sum of net investment income and net realized and unrealized gains (losses) on investments, was income of $1.6 billion in the year ended December 31, 2024, compared to $1.7 billion in the year ended December 31, 2023, a decrease of $41.2 million. The primary drivers of the lower total investment result include an increase of $442.4 million in net realized and unrealized losses on investments, which was partially offset by an increase in net investment income of $401.2 million. The change in net realized and unrealized gains (losses) on investments was a result of net realized and unrealized losses on fixed maturity investments of $246.4 million in the year ended December 31, 2024, compared to net realized and unrealized gains of $292.1 million in the year ended December 31, 2023, primarily due to increases in yields on longer duration assets during 2024, compared to decreases in 2023. Offsetting the increase in net unrealized losses on fixed maturity investments was an increase in net realized and unrealized gains on other investments of $159.4 million, driven by an increase in the value of our investment in TWFG as a result of TWFG, Inc.’s initial public offering in 2024. The increase in net investment income was due to a combination of higher average invested assets, primarily resulting from the Validus Acquisition, and higher yielding assets in the fixed maturity investments portfolio;
Read it in 10-K Feb 12, 2025 at sec.govopen_in_new
RewordedMD&A
Year ended December 31, 2025 2024 Change (in thousands, except per share amounts and percentages) Statements of Operations Highlights Year ended December 31, 2024 2023 Change Gross premiums written $ 11,738,420 $ 11,733,066 $ 8,862,366 $ 2,870,700 5,354 Net premiums written $ 9,870,200 $ 9,952,216 $ 7,467,813 $ 2,484,403 (82,016) Net premiums earned $ 9,901,182 $ 10,095,760 $ 7,471,133 $ 2,624,627 (194,578) Net claims and claim expenses incurred 5,615,839 5,332,981 3,573,509 1,759,472 282,858 Acquisition expenses 2,550,823 2,643,867 1,875,034 768,833 (93,044) Operational expenses 464,477 496,588 375,182 121,406 (32,111) Underwriting income (loss) $ 1,270,043 $ 1,622,324 $ 1,647,408 $ (25,084) (352,281) Net investment income $ 1,703,475 $ 1,654,289 $ 1,253,110 $ 401,179 49,186 Equity in earnings (losses) of other ventures (1) 71,332 47,087 24,245 Net realized and unrealized gains (losses) on investments 1,181,268 (27,840) 414,522 (442,362) 1,209,108 Total investment result (1) $ 1,626,449 2,956,075 $ 1,667,632 1,673,536 $ (41,183) 1,282,539 Net income (loss) $ 3,617,743 $ 2,960,532 $ 3,620,127 $ (659,595) 657,211 Net income (loss) available (attributable) to RenaissanceRe common shareholders $ 2,646,959 $ 1,834,985 $ 2,525,757 $ (690,772) 811,974 Net income (loss) available (attributable) to RenaissanceRe common shareholders per common share – diluted $ 56.03 $ 35.21 $ 52.27 $ (17.06) 20.82 Dividends per common share $ 1.60 $ 1.56 $ 1.52 $ 0.04 Key Ratios Year ended December 31, 2024 2023 Change Net claims and claim expense ratio – current accident year 67.7 % 61.3 % 53.9 % 7.4 6.4 pts Net claims and claim expense ratio – prior accident years (11.0) % (8.5) % (6.1) % (2.4) (2.5) pts Net claims and claim expense ratio – calendar year 56.7 % 52.8 % 47.8 % 5.0 3.9 pts Underwriting expense ratio 30.5 % 31.1 % 30.1 % 1.0 (0.6) pts Combined ratio 87.2 % 83.9 % 77.9 % 6.0 3.3 pts Return on average common equity 25.9 % 19.3 % 40.5 % (21.2) 6.6 pts Book Value At December 31, December 31, Change 2025 2024 2023 Change Book value per common share $ 247.00 $ 195.77 $ 165.20 $ 30.57 51.23 Accumulated dividends per common share 29.68 28.08 26.52 1.56 1.60 Book value per common share plus accumulated dividends $ 276.68 $ 223.85 $ 191.72 $ 32.13 Change 52.83 Year to date change in book value per common share 26.2 % Year to date change in book value per common share plus change in accumulated dividends 19.4 27.0 % 59.3 % (39.9) pts
Read it in 10-K Feb 11, 2026 at sec.govopen_in_new
RewordedMD&A
During 2024, 2025, our cash flows used in investing activities were $3.1 $2.2 billion, principally reflecting net purchases of equity investments of $1.6 billion, which were predominantly in fixed income exchange traded funds, net purchases of fixed maturity investments trading of $2.8 billion $616.9 million and net purchases of other investments of $438.2 $464.5 million, partially offset by cash flows from net sales settlements of short term investments derivatives of $174.5 $564.3 million.
Read it in 10-K Feb 11, 2026 at sec.govopen_in_new
RewordedMD&A
The $42.9 million includes $51.0 During 2025, $46.3 million of management fee income, income was recorded as a reduction to operational expenses (2024 - $51.0 million) and $(8.1) $32.4 million of performance fee income was recorded as an a reduction to acquisition expenses (2024 - increase to acquisition expenses (2023 - $34.4 million, $46.4 million and $(12.0) million, respectively). of $8.1 million).
Read it in 10-K Feb 11, 2026 at sec.govopen_in_new
RewordedMD&A
Such temporary differences are primarily due to net operating loss and capital loss carryforwards and GAAP versus tax basis accounting differences relating to unearned premiums, reserves for claims insurance-related assets and claim liabilities, investments, and deferred revenues and expenses, deferred finance charges, deferred underwriting results, accrued expenses, investments, value of in-force business, VOBA, deferred acquisition expenses, intangible assets, and amortization and depreciation, among others.
Read it in 10-K Feb 11, 2026 at sec.govopen_in_new
RewordedMD&A
As a result of our net income available to RenaissanceRe common shareholders result, in 2024, 2025 we generated an annualized return on average common equity of 19.3% 25.9% and our book value per common share increased from $165.20 at December 31, 2023 to $195.77 at December 31, 2024, a 19.4% 2024 to $247.00 at December 31, 2025, an 26.2% increase, or an 27.0% increase, after considering the change in accumulated dividends paid to our common shareholders.
Read it in 10-K Feb 11, 2026 at sec.govopen_in_new
RewordedMD&A
Actual FAL posted for Syndicate 1458 at December 31, 2024 2025 by RenaissanceRe Corporate Capital (UK) Limited CCL was $912.0 million (2024 - $952.3 million (2023 - $935.8 million), supported by a $952.3 million deposit of cash and fixed maturity securities (2023 - $710.8 million deposit of cash and fixed maturity securities and $225.0 million letter of credit). securities.
Read it in 10-K Feb 11, 2026 at sec.govopen_in_new
RewordedMD&A
Performance fees are based on the performance of the individual vehicles or products, and may be zero or negative in a particular period if, for For example, large losses occur, which can could potentially result in no performance fees or the reversal of previously accrued performance fees.
Read it in 10-K Feb 11, 2026 at sec.govopen_in_new
RewordedMD&A
Performance fees are based on the performance of the individual vehicles or products, products and may be zero or negative in a particular period if, for example, large losses occur, which can potentially result in no performance fees or the reversal of previously accrued performance fees. period.
Read it in 10-K Feb 11, 2026 at sec.govopen_in_new
RewordedMD&A
Net negative impact on net income (loss) available (attributable) to RenaissanceRe common shareholders is the sum of (1) net negative impact on underwriting result and result, (2) redeemable noncontrolling interest, both before consideration of any related interest and (3) income tax benefit (expense). (expense) beginning in the first quarter of 2025.
Read it in 10-K Feb 11, 2026 at sec.govopen_in_new
RewordedMD&A
To the extent that appropriately priced coverage is available, we anticipate continued use of retrocessional reinsurance to reduce the impact of large losses on our financial results and to manage our portfolio of risk; however, the buying of ceded reinsurance in our Property segment is based on market opportunities and is not based on placing a specific reinsurance program each year.
Read it in 10-K Feb 11, 2026 at sec.govopen_in_new
RewordedMD&A
(1)Reflects total fee income earned through from third-party capital management as well as various joint ventures, managed funds activities and certain structured retrocession agreements to reinsurance products which we are a party, is recorded through underwriting income (loss) as a decrease (increase) to operational expenses or acquisition expenses.
Read it in 10-K Feb 11, 2026 at sec.govopen_in_new
RewordedMD&A
In addition, our Common stocks are managed pursuant to diversified public equity investments include securities mandates with third-party investment managers and also includes more concentrated public equity positions that we invest in through our strategic investment portfolio.
Read it in 10-K Feb 11, 2026 at sec.govopen_in_new
Quiet changesMD&A
Debt and Credit Facilities” in our “Notes to the Consolidated Financial Statements” for additional information related to our significant debt and credit facilities.
Read it in 10-K Feb 11, 2026 at sec.govopen_in_new